Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shigematsu Works CoTSE:7980 -2.42%82 Debt-to-EBITDA is 1.24 as of Mar. 2026, which is 61% below its 10-year median of 3.16. GuruFocus rates TSE:7980 with a GF Score™ of 82/100 and a GF Value™ of 円967.20 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Shigematsu Works Co ranks worse than 72.52% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Shigematsu Works Co's Debt-to-EBITDA or its related term are showing as below:
TSE:7980'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.77 Med: 3.16 Max: 4.63
Current: 3.42
During the past 13 years, the highest Debt-to-EBITDA Ratio of Shigematsu Works Co was 4.63. The lowest was 1.77. And the median was 3.16.
TSE:7980's Debt-to-EBITDA is ranked worse than 72.52% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs TSE:7980: 3.42
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Shigematsu Works Co Debt-to-EBITDA Related Terms
Shigematsu Works Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Shigematsu Works Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7980 vs ISRG, BDX, MDLN: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Shigematsu Works Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shigematsu Works Co Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shigematsu Works Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shigematsu Works Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Shigematsu Works Co (TSE:7980) has a Debt-to-EBITDA of 1.24 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Shigematsu Works Co. This is 61% below median its historical median of 3.16. Over the past decade, Shigematsu Works Co's Debt-to-EBITDA has ranged from 1.77 to 4.63. According to the industry distribution chart, Shigematsu Works Co ranks #343 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 72.5%.
Is Shigematsu Works Co's Debt-to-EBITDA too high?
Shigematsu Works Co's current Debt-to-EBITDA of 1.24 is 61% below median its 10-year median of 3.16. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 4.63. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.62. Shigematsu Works Co's value of 1.24 is 23.5% below this industry median. Based on the distribution chart, Shigematsu Works Co ranks #343 out of 473 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shigematsu Works Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shigematsu Works Co's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shigematsu Works Co ranks #343 out of 473 companies for Debt-to-EBITDA. This places Shigematsu Works Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.62. Shigematsu Works Co's value of 1.24 is 23.5% below this benchmark. Historically, Shigematsu Works Co's own Debt-to-EBITDA has ranged from 1.77 to 4.63 over the past decade. While the company's 10-year median is 3.16 vs. the industry median of 1.62, Shigematsu Works Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.62, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shigematsu Works Co's current Debt-to-EBITDA of 1.24 is 23.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Shigematsu Works Co. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shigematsu Works Co's current Debt-to-EBITDA is 1.24, which is 61% below median its own 10-year median of 3.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shigematsu Works Co stock overvalued right now?
Based on GuruFocus' analysis, Shigematsu Works Co (TSE:7980) is currently considered Modestly Undervalued. The stock's GF Value™ is 円967.20, compared to a current price of 円847.00 — trading 12.4% below its estimated fair value. The current Debt-to-EBITDA is 1.24, which is 61% below median its 10-year median of 3.16 and 23.5% below the Medical Devices & Instruments industry median of 1.62. Shigematsu Works Co's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Shigematsu Works Co (TSE:7980), the current Debt-to-EBITDA is 1.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shigematsu Works Co (TSE:7980) Overvalued in 2026?
Based on GuruFocus' analysis, Shigematsu Works Co stock appears to be undervalued.
The current stock price of 円847.00 is trading 12.4% below its estimated GF Value™ of 円967.20.
GuruFocus considers Shigematsu Works Co to be Modestly Undervalued.
Key valuation signals for TSE:7980:
Debt-to-EBITDA: 1.24 (61% below median its 10-year median of 3.16)
GF Value™: 円967.20 vs. price of 円847.00 (12.4% below fair value)
Industry Position: 23.5% below the Medical Devices & Instruments median (#343 of 473)
No single metric tells the full story. See the TSE:7980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shigematsu Works Co Ltd is a Japan based company engaged in the safety business. It manufactures personal and respiratory protective devices related to fire and industrial safety, equipment for air purifying, emergency and rescue operations. The company offers products such as gas respirators, chemical cartridge respirators, particulate respirators, self-contained breathing apparatus, powered air-purifying respirators, supplied-air respirators, eye protector, face shields, earmuffs, safety belts, protective clothing, protective gloves, stretchers, oxygen meters and other related products. The products offered by the organization has application in various industries including textile, chemical, automobile, fishery, mining, warehouse and others.
82GF Score
Get the complete analysis for TSE:7980
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7980 has been successfully added to your 
